J.P. Morgan Private Wealth Advisors LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 43 filers reported holding UROGEN PHARMA LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q1 2019$537,000
-12.5%
14,543
+2.1%
0.00%
-25.0%
Q4 2018$614,000
-19.9%
14,250
-12.3%
0.00%0.0%
Q3 2018$767,000
+25.7%
16,250
+32.7%
0.00%
+33.3%
Q2 2018$610,000
+0.2%
12,2500.0%0.00%
-25.0%
Q1 2018$609,000
+33.6%
12,2500.0%0.00%
+33.3%
Q4 2017$456,000
+18.1%
12,2500.0%0.00%0.0%
Q3 2017$386,000
+74.7%
12,2500.0%0.00%
+50.0%
Q2 2017$221,00012,2500.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q1 2018
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 789,297$37,278,00070.39%
Wildcat Capital Management, LLC 375,479$17,734,00013.68%
Consonance Capital Management LP 1,515,422$71,573,0003.85%
MENORA MIVTACHIM HOLDINGS LTD. 2,499,870$118,069,0003.20%
SHIKIAR ASSET MANAGEMENT INC 78,425$3,704,0001.44%
MEITAV INVESTMENT HOUSE LTD 584,104$27,799,0001.36%
HIGHLINE CAPITAL MANAGEMENT, L.P. 331,900$15,676,0000.72%
Clal Insurance Enterprises Holdings Ltd 310,000$14,641,0000.39%
DAFNA Capital Management LLC 15,000$708,0000.29%
MOODY ALDRICH PARTNERS LLC 18,200$860,0000.25%
View complete list of UROGEN PHARMA LTD shareholders